By Ben Butkus

A group of scientists from the University of Copenhagen has devised a qPCR-based assay to quantitatively measure the intracellular concentration of small-interfering RNAs and thus gauge the effectiveness of carrier-mediated siRNA delivery.

Although it is still in the testing phase, the researchers believe the tool will improve upon existing methods for assessing the ability of different types of nanocarriers to deliver siRNA payloads for RNA interference-based pharmaceutical applications.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.